

[ Wed, Sep 18th 2024
] - WOPRAI

[ Fri, Aug 30th 2024
] - WOPRAI

[ Thu, Jun 27th 2024
] - WOPRAI

[ Thu, Jun 13th 2024
] - WOPRAI

[ Tue, May 07th 2024
] - WOPRAI

[ Tue, Apr 30th 2024
] - WOPRAI

[ Tue, Mar 26th 2024
] - WOPRAI

[ Thu, Mar 14th 2024
] - WOPRAI

[ Tue, Mar 12th 2024
] - WOPRAI

[ Wed, Mar 06th 2024
] - WOPRAI

[ Tue, Feb 20th 2024
] - WOPRAI

[ Fri, Dec 29th 2023
] - WOPRAI

[ Mon, Nov 06th 2023
] - WOPRAI

[ Fri, Sep 01st 2023
] - WOPRAI

[ Tue, Aug 15th 2023
] - WOPRAI
[ Tue, Aug 15th 2023
] - WOPRAI

[ Thu, Aug 03rd 2023
] - WOPRAI

[ Mon, Jul 17th 2023
] - WOPRAI

[ Mon, Jun 12th 2023
] - WOPRAI

[ Wed, May 10th 2023
] - WOPRAI

[ Wed, Apr 26th 2023
] - WOPRAI
[ Wed, Apr 26th 2023
] - WOPRAI

[ Tue, Mar 14th 2023
] - WOPRAI

[ Tue, Mar 07th 2023
] - WOPRAI

[ Fri, Nov 11th 2022
] - WOPRAI

[ Wed, Mar 16th 2022
] - WOPRAI

[ Mon, Mar 14th 2022
] - WOPRAI

[ Mon, Feb 07th 2022
] - WOPRAI

[ Wed, Dec 22nd 2021
] - WOPRAI

[ Tue, Aug 03rd 2021
] - WOPRAI

[ Tue, Jul 27th 2021
] - WOPRAI

[ Wed, May 12th 2021
] - WOPRAI

[ Tue, Apr 06th 2021
] - WOPRAI

[ Thu, Apr 01st 2021
] - WOPRAI

[ Tue, Mar 09th 2021
] - WOPRAI

[ Mon, Nov 16th 2020
] - WOPRAI

[ Thu, Aug 06th 2020
] - WOPRAI

[ Fri, Apr 24th 2020
] - WOPRAI

[ Mon, Jan 27th 2020
] - WOPRAI

[ Wed, Oct 23rd 2019
] - WOPRAI


[ Wed, Jul 24th 2019
] - WOPRAI

[ Mon, Apr 15th 2019
] - WOPRAI

[ Fri, Mar 22nd 2019
] - WOPRAI

[ Mon, Dec 10th 2018
] - WOPRAI

[ Mon, Jul 23rd 2018
] - WOPRAI


[ Tue, Mar 27th 2018
] - WOPRAI

[ Thu, Mar 15th 2018
] - WOPRAI

[ Wed, Jan 24th 2018
] - WOPRAI

[ Fri, Oct 27th 2017
] - WOPRAI
[ Fri, Oct 27th 2017
] - WOPRAI



[ Mon, Apr 01st 2013
] - WOPRAI

[ Thu, Mar 28th 2013
] - WOPRAI

[ Wed, Feb 27th 2013
] - WOPRAI

[ Thu, Jan 03rd 2013
] - WOPRAI

[ Mon, Dec 17th 2012
] - WOPRAI
Sumant Kulkarni Maintained (zvra) at Strong Buy with Decreased Target to $22 on, Sep 18th, 2024
Sumant Kulkarni of Canaccord Genuity, Maintained "Zevra Therapeutics, Inc." (ZVRA) at Strong Buy with Decreased Target from $24 to $22 on, Sep 18th, 2024.
Sumant has made no other calls on ZVRA in the last 4 months.
There are 2 other peers that have a rating on ZVRA. Out of the 2 peers that are also analyzing ZVRA, 0 agree with Sumant's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Sumant
- Louise Chen of "Cantor Fitzgerald" Reiterated at Buy on, Wednesday, August 14th, 2024
- Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $18 on, Monday, August 5th, 2024